← FDA DRUG APPROVALS

FDA ANDA · ANDA209170

DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL

Sponsor: NAARI PTE

APPLICATION
ANDA209170
TYPE
ANDA
ORIGINAL APPROVAL
2017-06-05
LATEST ACTION
2017-06-05
ROUTE
ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DESOGESTREL AND ETHINYL ESTRADIOLPrescription
DESOGESTREL 0.15MG,N/A, ETHINYL ESTRADIOL 0.02MG,0.01MG · TABLET · ORAL-28

Approval history

2017-06-05UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →